HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Consumers Vulnerable To False Supplement Claims, Plus Products For ‘Gym Rats’ Get US DoJ Attention

Executive Summary

DoJ criminal prosecutions in supplement sector have focused on undisclosed steroids targeted for consumers typically aware the products contain more than labels indicate. But weighing consumers’ vulnerability to false claims also factors in federal prosecutors’ decisions on seeking criminal charges in consumer health products sector.

You may also be interested in...



DoJ's COVID-19 Fraud Enforcement Gets A Director

Associate Deputy Attorney General Kevin Chambers oversees DoJ’s enforcement and prosecution of COVID-19 criminal and civil fraud.

FDA Left Out Of $80M For Stopping Consumer Product Fraud In Latest US COVID-19 Relief Act

American Rescue Plan Act appropriated $50m to Consumer Product Safety Commission and $30.4m to Federal Trade Commission for COVID-19-related enforcement. Neither agency received funding for pandemic-related enforcement in previous relief packages.

After Guilty Plea In COVID-19 Scam, Utah Firm Will Cooperate In Prosecution Of Former Owner

Gordon Pedersen was indicted on criminal charges linked to posing as a physician to fraudulently promote and sell ingestible silver-based products as a cure for COVID-19 despite having no evidence his products could treat or cure the disease.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152993

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel